" the basic medicines catalogue " violates " Cheap " Principle

" the basic medicines catalogue " violates " Cheap " Principle
March 9, " the deputy to the National People's Congress of drugmaker of sound responsibility 2010, forum of member of the CPPCC National Committee " jointly hosted by each medical association of China Held in Beijing.
Have invited the representatives of the two conferences of drugmakers from all parts of the country to participate in in forum, with every association, society leader, organize discussion on the industry, trade, three great themes of enterprise, the first is how to improve the policy environment of the trade, how the second promotes the industry to develop motive force, how the third supports enterprises to enlarge and strengthen. Everybody publishes their own views and views to some problems existing in present medical market, current situation of medical reform policy, traditional Chinese medicine, enterprise's development,etc..
Song LiHua, fit group's Chairman of department's biological engineering in Anhui
Song LiHua: One of the principles of the new medical reform is cheap, let ordinary people think highly of the disease, let effective the intersection of resource and application, the " the basic the intersection of medicines and catalogue " violate the principle seriously, also violated guidelines of developing industry's development of traditional Chinese medicine in a more cost-effective manner.
Around developing the angle of nationality's medical industry, two things have happened recently. Everybody knows the country issued " medical insurance catalogue " last December, divided Class A and Class B again inside, after this catalogue issues, we find inside the class-B catalogue (it is said the class-A catalogue have too) ,A lot of variety contents go wrong, I give one example, everybody knows interferon, interferon of Alpha is a first-selected medicine to treat hepatitis B and hepatitis C, this Alpha interferon is the first production domesticization too initially, then enter cultivation of more than 10 years, having already formed the large-scale production, 14 enterprises produce interferon of Alpha at home, sanction already time nearly 20 years up to now from Changchun, basically national hepatitis B and demand for hepatitis C, especially hepatitis B, interferon is a first-selected medicine inside our healing solution, the basic medicine of such a therapeutic hepatitis B, the price drops to dozens of yuan now from more than 200 yuan of the initial foreign products, twenty or thirty yuan on condition that call for bid and demand a lower price of some hospitals, national development and reform committee drop to this product seven times, it was a very luxurious thing that the last hepatitis B patient treated with interferon, but ordinary people can treat with interferon with dozens of yuan now.
Have not noticed such a phenomenon exactly when treating the catalogue in our social insurance department, been sought loopholes by the trans-corporation finally, one kind of one is even interferon of Alpha, but got involved long-efficiency interferon of a molecule lists in " basic medicines catalogue ", accept already the ordinary people, the intersection of curative effect and precise, the intersection of quality and reliable such an ordinary the intersection of Alpha and interferon get rid of in outside hepatitis B wipe out catalogue. Someone it speaks foreign products to be high quality and curative effect fine, in term of the expert's angle I, the curative effect that these two kinds of interferon treat hepatitis B is totally the same, only that can have one injection with one week, ordinary interferon wants to have three injection in one week, this is the only difference, but one price is that one in the sky is underground, one call for bid on average price 1200, add, it raises the price to be 1300 more than by 15% hospital, and ordinary the intersection of Alpha and interferon we in 48 on average, it is more than 50 yuan to add 15% of the hospitals and raise the price, has treated the expenses 150, 160 yuan, after such a " basic medicines catalogue " issues, the hepatitis B patient reaches the hospital treatment, he is a medical insurance range, can only use importing, expensive long-efficiency interferon, how much does the country pay more? Pay more medical insurance fund of 30,000 yuan in a course of treatment, the patient should pay a thousand yuan of Forth Five-Year Plan Period more too by oneself, have caused the loss of a large amount of of fund of medical insurance. One of the principles of the new medical reform is cheap, let ordinary people think highly of the disease, let effective the intersection of resource and application, the " the basic the intersection of medicines and catalogue " violate the principle seriously, also violated guidelines of developing industry's development of traditional Chinese medicine in a more cost-effective manner.
" self- medicine is treated " the reporter the soda
|